Pharmaceutical polymorphism: The phenomenon affecting the performance of drug and an approach to enhance drug solubility, stability and bioavailability

Journal Title: World Journal of Pharmaceutical Sciences - Year 2016, Vol 4, Issue 9

Abstract

Pharmaceutical solids can exist in different physical forms. Polymorphism is often characterized as the ability of a drug substance to exist two or more crystalline phases that have different arrangements and conformations of the molecules in the crystal lattice. In past decades, there have been significant efforts on the discovery, selection and control of the solid forms of active pharmaceutical ingredients and bulk drugs. Polymorphs and solvates of a pharmaceutical solid can have different chemical and physical properties such as melting point, chemical reactivity, apparent solubility, dissolution rate, optical and electrical properties, vapour pressure, and density. Polymorphism must be controlled to prevent possible ineffective therapy and improper dosage. Drugs with low water solubility are predisposed to poor and variable oral bioavailability and, therefore, to variability in clinical response, that might be overcome through an appropriate formulation of the drug. Polymorphs (anhydrous and solvate/hydrate forms) may resolve these bioavailability problems Number of strategies exists for enhancing the bioavailability of those drugs, these strategies are greatly dependent on the physical and chemical nature of the molecules being developed. This review will discuss the applied nature of polymorphism starting from their preparation, characterization and pharmaceutical importance with a special emphasis on drug.

Authors and Affiliations

Priyanka Maurya

Keywords

Related Articles

Gemistocytic Glioblastoma: A Case Report

Introduction: Glioblastoma Multiforme (GBM) is the most common and lethal malignant primary brain tumor. It is classified by the World Health Organization (WHO) as a group of diffusely infiltrating astrocytoma, represent...

Role of blood urea, creatinine and uric acid as a marker of renal function tests in hypertensive patients

Hypertension is both a cause and consequence of renal disease, but the prevalence of kidney disease throughout the diagnostic spectrum of blood pressure has not been established. The presence of hypertension with renal d...

Evaluation of antioxidant activity of methanolic extract, fractions and pure compounds of Syzygium aromaticum

Antioxidant activity of methanolic extract of the Syzygium aromaticum, its fractions and pure compounds oleanolic acid (1), nigricin (2), 3, 4, 3′-tri-O-methylellagic acid (3), 2α-hydroxyoleanolic acid (4) and β-sitoster...

Anti-inflammatory and analgesic activity of methanolic bark extracts of Zanthoxylum Armatum

A comprehensive study on the phytochemical contents and biological activities of different extracts from bark of Zanthoxylum armatum was studied. The extracts of the bark parts contained various levels of phenols, flavon...

Swami Vivekanand Subharti University (SVSU), Meerut

Aim and Objective: To assess the drug utilization pattern of patients with Bipolar Affective Disorder (BPAD) in the Outpatient department of Psychiatry of a tertiary care hospital. Methods: It is a Cross sectional observ...

Download PDF file
  • EP ID EP202572
  • DOI -
  • Views 75
  • Downloads 0

How To Cite

Priyanka Maurya (2016). Pharmaceutical polymorphism: The phenomenon affecting the performance of drug and an approach to enhance drug solubility, stability and bioavailability. World Journal of Pharmaceutical Sciences, 4(9), 411-419. https://europub.co.uk/articles/-A-202572